Cementos Pacasmayo
CPAC
12.22
-0.07
-0.57%
Cementos Pacasmayo
US · CPAC
#3216 by market cap
12.22
-0.07
-0.57%
Live - 5344 symbols - heartbeat 261s ago
· 2026-10-07 19:54
After-hours
12.22
0.00%
- Market cap
- 1.05B
- P/E (TTM)i
- 19.58
- P/Bi
- 2.83
- EPSi
- 0.52
- Div yieldi
- 5.00%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on CPAC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.61, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +7.02% YoY
Margins
- Gross margin
- 38.12%
- Operating margin
- 20.06%
- Net margin
- 7.28%
Key ratios & quality
- Enterprise valuei
- 2.41B
- Altman Z-Scorei
- 1.61
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.26B | 1.39B | 1.30B | 1.94B | 2.12B | 1.95B | 1.98B | 2.12B |
| Gross profit | 466.73M | 486.90M | 375.29M | 559.43M | 652.03M | 689.45M | 728.53M | 806.87M |
| Selling & admin expenses | 199.45M | 199.46M | 180.05M | 224.89M | 268.51M | 281.83M | 308.98M | 357.69M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 242.02M | 272.01M | 173.65M | 318.25M | 355.32M | 385.50M | 391.03M | 424.73M |
| Pretax profit | 116.14M | 194.35M | 85.90M | 224.11M | 262.42M | 245.71M | 296.19M | 267.98M |
| Tax | 41.00M | 62.31M | 28.00M | 70.94M | 85.59M | 76.81M | 97.31M | 113.77M |
| Net profit | 75.15M | 132.05M | 57.89M | 153.17M | 176.83M | 168.90M | 198.88M | 154.21M |
| Basic EPS | 1 | 2 | 1 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 0.90 | 1.55 | 0.70 | 1.80 | 2.05 | 1.95 | 2.30 | 1.80 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 499.17M | 484.10M | 574.07M | 559.54M | 555.67M | 558.85M |
| Gross profit | 183.36M | 179.69M | 223.89M | 219.93M | 234.39M | 221.13M |
| Selling & admin expenses | 86.23M | 87.30M | 96.65M | 84.77M | 89.99M | 85.49M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 95.64M | 90.73M | 121.25M | 117.11M | 139.69M | 136.43M |
| Pretax profit | 73.94M | 69.63M | 106.37M | 18.03M | 118.02M | 115.07M |
| Tax | 21.27M | 21.81M | 34.86M | 35.83M | 36.07M | 37.83M |
| Net profit | 52.67M | 47.82M | 71.51M | -17.80M | 81.95M | 77.24M |
| Basic EPS | 1 | 1 | 1 | 0 | 1 | 1 |
| Diluted EPS | 0.60 | 0.55 | 0.85 | -0.20 | 0.95 | 0.90 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 619.33M | 748.33M | 877.74M | 1.01B | 1.19B | 992.25M | 992.50M | 949.75M |
| Cash & ST investments | 49.07M | 68.27M | 308.91M | 273.40M | 168.67M | 90.19M | 72.72M | 53.57M |
| Inventory | 424.78M | 519.00M | 460.61M | 605.18M | 884.97M | 791.07M | 774.00M | 707.14M |
| Total assets | 2.86B | 2.93B | 3.02B | 3.20B | 3.31B | 3.22B | 3.17B | 3.10B |
| Total current liabilities | 261.84M | 352.68M | 265.07M | 722.16M | 953.14M | 689.39M | 765.56M | 872.61M |
| Short-term debt | 60.82M | 98.77M | 1.53M | 452.82M | 620.91M | 387.15M | 461.30M | 537.23M |
| Long-term debt | 1.02B | 1.00B | -- | 1.09B | 974.26M | 1.19B | 1.03B | 879.81M |
| Total liabilities | 1,413,261,000.00 | 1,509,907,000.00 | 1,648,729,000.00 | 2,005,967,000.00 | 2,119,026,000.00 | 2,031,727,000.00 | 1,952,945,000.00 | 1,912,001,000.00 |
| Total equity | 1.45B | 1.42B | 1.37B | 1.20B | 1.20B | 1.19B | 1.21B | 1.19B |
| Retained earnings | 519.29M | 497.20M | 456.63M | 271.60M | 268.62M | 261.99M | 285.35M | 264.03M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 1.01B | 1.07B | 1.16B | 949.75M | 1.00B | 1.10B |
| Cash & ST investments | 54.75M | 80.64M | 182.41M | 53.57M | 78.57M | 199.46M |
| Inventory | 750.45M | 749.32M | 750.72M | 707.14M | 695.44M | 651.50M |
| Total assets | 3.18B | 3.23B | 3.29B | 3.10B | 3.13B | 3.21B |
| Total current liabilities | 758.22M | 795.73M | 827.31M | 872.61M | 855.12M | 905.06M |
| Short-term debt | 4.76M | 499.01M | 499.22M | 537.23M | 590.20M | 574.66M |
| Long-term debt | -- | 957.32M | 918.57M | 879.81M | 841.05M | 802.29M |
| Total liabilities | 1,919,088,000.00 | 1,914,964,000.00 | 1,907,766,000.00 | 1,912,001,000.00 | 1,856,910,000.00 | 1,854,426,000.00 |
| Total equity | 1.27B | 1.31B | 1.38B | 1.19B | 1.27B | 1.35B |
| Retained earnings | 338.02M | 385.84M | 457.35M | 264.03M | 345.97M | 423.22M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 203.63M | 205.14M | 331.37M | 170.56M | 111.82M | 412.32M | 321.14M | 360.63M |
| Depreciation & amortization | 129.78M | 129.82M | 139.17M | 135.57M | 138.54M | 144.20M | 158.25M | 159.48M |
| Free cash flow | 92.36M | 122.12M | 278.82M | 76.02M | -66.68M | 123.02M | 240.26M | 241.90M |
| Dividends paid | -171.79M | -120.98M | -143.62M | -336.82M | -179.82M | -175.43M | -175.05M | -175.46M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 49.07M | 68.27M | 308.91M | 273.40M | 81.77M | 90.19M | 72.72M | 53.57M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 59.68M | 50.18M | 169.99M | 80.78M | 40.64M | 191.00M |
| Depreciation & amortization | 38.99M | 39.57M | 39.31M | 41.61M | 38.24M | 38.38M |
| Free cash flow | 24.23M | 27.68M | 143.21M | 46.79M | 11.58M | 175.88M |
| Dividends paid | -454.00K | -120.00K | -125.00K | -174.76M | -470.00K | -22.00K |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 54.75M | 80.64M | 182.41M | 53.57M | 78.57M | 199.46M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.19 | 9.19 | 4.15 | 11.95 | 14.79 | 14.16 | 16.55 | 12.83 |
| ROA %i | 2.70 | 4.56 | 1.95 | 4.93 | 5.43 | 5.17 | 6.23 | 4.92 |
| ROIC %i | 4.22 | 6.84 | 4.02 | 10.42 | 11.33 | 8.39 | 9.51 | 7.90 |
| 5-year avg ROE %i | 7.53 | 7.40 | 6.04 | 7.21 | 9.05 | 10.85 | 12.32 | 14.06 |
| EBIT margin %i | 13.06 | 18.41 | 12.09 | 15.27 | 16.03 | 17.77 | 19.98 | 16.98 |
| FCF / sales %i | 7.32 | 8.77 | 21.51 | 3.92 | -- | 6.31 | 12.15 | 11.43 |
| Current ratioi | 2.37 | 2.12 | 3.31 | 1.40 | 1.25 | 1.44 | 1.30 | 1.09 |
| Quick ratioi | 0.58 | 0.54 | 1.48 | 0.52 | 0.28 | 0.27 | 0.27 | 0.22 |
| Debt / assetsi | 37.82 | 37.59 | 0.22 | 48.45 | 48.20 | 49.08 | 47.46 | 46.03 |
| LT debt / equityi | 70.45 | 70.56 | 0.37 | 91.85 | 81.72 | 100.34 | 85.84 | 74.80 |
| Interest coveragei | 3.39 | 4.13 | 2.21 | 4.12 | 4.42 | 3.44 | 3.99 | 3.93 |
| Revenue CAGR (3Y) %i | 0.86 | 4.04 | 2.02 | 15.34 | 14.96 | 14.58 | 0.69 | 0.02 |
| Net income CAGR (3Y) %i | -29.14 | 4.36 | -14.85 | 25.93 | 10.22 | 42.89 | 9.09 | -4.46 |
| FCF CAGR (3Y) %i | -- | 5.29 | 17.31 | -6.29 | -- | -23.87 | 46.76 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 16.14 | 16.23 | 16.31 | 12.83 | 14.45 | 15.98 |
| ROA %i | 6.32 | 6.60 | 6.75 | 4.92 | 5.81 | 6.62 |
| ROIC %i | 12.84 | 9.83 | 9.76 | 7.90 | 11.54 | 9.40 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 19.79 | 20.12 | 20.09 | 16.98 | 18.49 | 19.84 |
| FCF / sales %i | 14.79 | 12.40 | 13.11 | 11.43 | 10.55 | 16.79 |
| Current ratioi | 1.33 | 1.34 | 1.40 | 1.09 | 1.17 | 1.22 |
| Quick ratioi | 0.27 | 0.30 | 0.42 | 0.22 | 0.26 | 0.38 |
| Debt / assetsi | 0.57 | 45.48 | 43.42 | 46.03 | 46.06 | 43.25 |
| LT debt / equityi | 1.06 | 73.79 | 67.19 | 74.80 | 66.89 | 60.08 |
| Interest coveragei | 4.11 | 4.34 | 4.58 | 3.93 | 4.47 | 5.04 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Cement, concrete, pavement, mortar and precast is the largest reported line at 97.37% of revenue, across 3 reported segments.
- The next-largest line, Construction supplies, is a distant second at 1.61% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Cement, concrete, pavement, mortar and precast97.37%
Construction supplies1.61%
Others1.02%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.